Overview
Ben Gerber is a primary care provider, practicing in Internal Medicine in Worcester, Massachusetts. Dr. Gerber is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Adie Syndrome, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.
His clinical research consists of co-authoring 101 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Severe Acute Respiratory Syndrome (SARS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
55 Lake Ave N, Worcester, MA 01655
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
BIDMC - Center For Virology And Vaccine Research
Dan Barouch is an Internal Medicine provider in Boston, Massachusetts. Dr. Barouch is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Zika Virus Disease, and COVID-19.
Ranjit Sah is a primary care provider, practicing in Internal Medicine in Brighton, Massachusetts. Dr. Sah is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Monkeypox, Smallpox, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Vitrectomy.
Brigham And Women's Hospital
Dr. Chanu Rhee is an infectious disease and critical care physician, Medical Director of Infection Control at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital followed by an infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and an MPH degree from the Harvard T.H. Chan School of Public Health. Dr. Rhee is internationally recognized for his expertise and contributions to the epidemiology, surveillance, diagnosis, and treatment of sepsis, particularly through the innovative use of electronic health record data to generate insights that inform clinical practice, quality improvement, and public health policy. His areas of focus also include infection prevention and control, antimicrobial resistance and stewardship, infections in immunocompromised patients, and the care of critically ill patients. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham healthcare system and has participated in many national committees focused on enhancing sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.Dr. Rhee attends clinically on the transplant / oncology infectious disease service and the Medical ICU at Brigham and Women’s Hospital. In his role as Medical Director of Infection Control, he leads institutional efforts to prevent healthcare-associated infections, investigate outbreaks, and advance patient safety. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine. He has served as principal or lead investigator on multiple federally funded grants, has authored over 200 peer-reviewed articles, and is recognized by ScholarGPS as one of the world’s most highly cited and influential experts on sepsis. Dr. Rhee is rated as a Distinguished provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are Sepsis, Severe Acute Respiratory Syndrome (SARS), Hospital-Acquired Pneumonia, and Pneumonia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adie SyndromeDr. Gerber isAdvanced. Learn about Adie Syndrome.
- Type 2 Diabetes (T2D)Dr. Gerber isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Chromophobe Renal Cell CarcinomaDr. Gerber isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic Kidney DiseaseDr. Gerber isExperienced. Learn about Chronic Kidney Disease.
- Clear Cell SarcomaDr. Gerber isExperienced. Learn about Clear Cell Sarcoma.
- COVID-19Dr. Gerber isExperienced. Learn about COVID-19.
- Diabetic RetinopathyDr. Gerber isExperienced. Learn about Diabetic Retinopathy.
- Familial Wilms Tumor 2Dr. Gerber isExperienced. Learn about Familial Wilms Tumor 2.

